Shattuck Labs, Inc.
STTK
Positions held
Your positionsSTTK isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $568.06M | Enterprise value | $362.43M | Trailing P/E | — | Forward P/E | -10.65 |
| PEG | — | Price / book | 2.70 | Beta | 1.10 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | -55.7% |
| Profit margin | 0.0% | ROE | -39.2% | ROA | -24.4% | Debt / equity | 0.01 |
| Current ratio | 27.59 | Free cash flow | -$21.22M | Analyst recommendation | strong_buy | Mean target | $15.22 |
| 52w high | $8.33 | 52w low | $1.70 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $1.0M | $0.0M | — |
| Op margin | — | — | — | -1071.6% | — | — |
| Net income | -$15.2M | -$14.8M | -$12.6M | -$10.1M | -$12.5M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$16.2M | -$15.5M | -$13.4M | -$10.7M | -$13.0M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $1.0M | $5.7M | $1.7M | $0.7M |
| Op margin | -5150.8% | -1408.3% | -5549.6% | -15848.0% |
| Net income | -$48.8M | -$75.4M | -$87.3M | -$102M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$51.5M | -$80.6M | -$92.0M | -$103M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-01 · Update: Wedbush Lifts Price Target on Shattuck Labs to $14 From $11, Keeps Outperform Rating
2026-10-01 · Wedbush Lifts Price Target on Shattuck Labs to $14 From $11, Keeps Outperform Rating
2026-10-01 · Shattuck Labs Plans Phase 2 Trial of Chronic Inflammatory Skin Disease Drug
2026-09-29 · Hut 8 Insider Sold Shares Worth $2,000,000, According to a Recent SEC Filing
2026-09-02 · Shattuck Labs Announces Participation in Upcoming September Investor Conferences
2026-08-24 · What Shattuck Labs Stock Topped the Market on Monday
2026-08-24 · Raymond James Initiates Coverage on Shattuck Labs With Strong Buy Rating, $18 Price Target
2026-08-20 · Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy?
2026-08-13 · Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade
2026-08-11 · Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights
2026-07-24 · Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday
Price (daily)
Full chart · RSI · MACD · patterns